Experimental Combination Treatment for Pancreatic Cancer Enters Phase II Trial
According to a story from Financial Buzz, the drug developer Rafael Pharmaceuticals, Inc., recently announced that a Phase II clinical trial that will test the company's experimental drug CPI-613 in…